244 related articles for article (PubMed ID: 36001314)
1. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer.
Minami CA; Bryan AF; Freedman RA; Revette AC; Schonberg MA; King TA; Mittendorf EA
JAMA Netw Open; 2022 Aug; 5(8):e2228524. PubMed ID: 36001314
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
3. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
[TBL] [Abstract][Full Text] [Related]
4. Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
Heidinger M; Maggi N; Dutilh G; Mueller M; Eller RS; Loesch JM; Schwab FD; Kurzeder C; Weber WP
World J Surg Oncol; 2023 Jun; 21(1):176. PubMed ID: 37287038
[TBL] [Abstract][Full Text] [Related]
5. Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
Wang T; Mott N; Miller J; Berlin NL; Hawley S; Jagsi R; Dossett LA
JAMA Netw Open; 2020 Sep; 3(9):e2017129. PubMed ID: 32960279
[TBL] [Abstract][Full Text] [Related]
6. Avoiding Overtreatment of Women ≥70 With Early-Stage Breast Cancer: A Provider-Level Deimplementation Strategy.
Mott NM; Markovitz NH; Wang T; Hughes TM; Pilewskie M; Jagsi R; Dossett LA
J Surg Res; 2023 Apr; 284():124-130. PubMed ID: 36566589
[TBL] [Abstract][Full Text] [Related]
7. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.
McEvoy AM; Poplack S; Nickel K; Olsen MA; Ademuyiwa F; Zoberi I; Odom E; Yu J; Chang SH; Gillanders WE
Breast Cancer Res Treat; 2020 Sep; 183(2):251-262. PubMed ID: 32651755
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
10. Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.
Wang T; Baskin A; Miller J; Metz A; Matusko N; Hughes T; Sabel M; Jeruss JS; Dossett LA
Ann Surg Oncol; 2021 Feb; 28(2):902-913. PubMed ID: 32651693
[TBL] [Abstract][Full Text] [Related]
11. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
[TBL] [Abstract][Full Text] [Related]
13. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
14. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.
Hrebinko KA; Bryce CL; Downs-Canner S; Diego EJ; Myers SP
Cancer; 2022 Jun; 128(12):2258-2268. PubMed ID: 35389517
[TBL] [Abstract][Full Text] [Related]
16. Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer.
Christian N; Heelan Gladden A; Friedman C; Gleisner-Patton A; Murphy C; Kounalakis N; Ahrendt G
Breast J; 2020 Feb; 26(2):133-138. PubMed ID: 31448508
[TBL] [Abstract][Full Text] [Related]
17. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
18. Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
Minami CA; Jin G; Schonberg MA; Freedman RA; King TA; Mittendorf EA
Ann Surg Oncol; 2022 Apr; ():. PubMed ID: 35385998
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
[TBL] [Abstract][Full Text] [Related]
20. Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
Matar R; Barrio AV; Sevilimedu V; Le T; Heerdt A; Morrow M; Tadros A
Ann Surg Oncol; 2022 Apr; 29(4):2263-2272. PubMed ID: 34994896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
